Prior research has suggested that 7% to 8% of patients with AMD develop hemorrhagic complications. In this study, the use of anticoagulants or antiplatelets was linked to a higher risk of intraocular ...
Sanofi has been granted a speedy review from the FDA for a gene therapy for geographic atrophy (GA), a complication of age-related macular degeneration (AMD), as it prepares to test it in a clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback